Lyell Immunopharma, Inc.
NASDAQ:LYEL
0.6063 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||
| Net Income
| -191.935 | -44.583 | -45.809 | -60.667 | -52.93 | -50.853 | -63.89 | -66.959 | -8.397 | -70.254 | -36.323 | -68.144 | -83.706 | -48.875 | -62.595 | -55.043 | -38.857 | -35.719 | -100.656 | -29.24 |
| Depreciation & Amortization
| 5.026 | 4.68 | 4.901 | 5.024 | 5.057 | 5.104 | 5.062 | 5.027 | 5.041 | 4.621 | 4.171 | 4.187 | 4.565 | 4.091 | 3.01 | 1.958 | 1.452 | 1.104 | 0.962 | 0.776 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | -18.152 | -1.645 | 1.278 | 0 | 93.896 | 0 | 0 | 0 | 37.377 | 1.09 | 0.996 | 0.043 | -4.384 | 0.213 | -0.061 | -1.38 |
| Stock Based Compensation
| 8.083 | 7.622 | 8.284 | 9.155 | 8.463 | 10.516 | 14.223 | 13.882 | 18.363 | 19.123 | 22.41 | 22.028 | 21.178 | 13.042 | 15.249 | 12.732 | 12.971 | 9.748 | 7.268 | 3.274 |
| Change In Working Capital
| 0.034 | 1.037 | -0.954 | -3.237 | 1.722 | 2.426 | 3.584 | -4.311 | -43.393 | 1.749 | -37.982 | -2.389 | 3.618 | 5.739 | -0.565 | -4.777 | 2.111 | 0.371 | -2.272 | -0.546 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| -2.036 | -0.568 | -0.517 | -0.113 | 0.425 | -1.41 | 0.38 | 2.069 | -0.526 | 0.023 | -1.767 | 2.937 | 0.099 | -0.988 | 0.346 | 0.634 | 0.338 | -0.293 | -1.244 | 0.921 |
| Other Working Capital
| 2.07 | 1.605 | -0.437 | -3.124 | 1.297 | 3.836 | 3.204 | -6.38 | -42.867 | 1.726 | -35.742 | -5.326 | 3.519 | 6.727 | -0.911 | -5.411 | 1.773 | 0.664 | -1.028 | -1.467 |
| Other Non Cash Items
| 131.55 | -3.798 | 14.087 | 27.025 | 15.205 | -3.234 | 0.582 | 6.149 | -105.777 | 7.658 | 3.146 | -3.534 | -16.205 | -0.619 | 9.958 | 11.49 | -0.025 | 2.655 | 5.837 | 3.524 |
| Operating Cash Flow
| -47.242 | -35.042 | -38.094 | -42.016 | -40.635 | -37.686 | -39.161 | -46.212 | -40.267 | -37.103 | -44.333 | -47.852 | -33.173 | -25.532 | -33.947 | -33.597 | -26.732 | -21.628 | -88.922 | -23.592 |
| Investing Activities: | ||||||||||||||||||||
| Investments In Property Plant And Equipment
| -0.044 | -0.059 | -0.331 | -0.03 | -0.025 | -0.195 | -0.933 | -1.533 | -4.582 | -2.791 | -7.17 | -9.733 | -10.268 | -11.599 | -24.447 | -19.19 | -24.881 | -12.641 | -7.078 | -6.881 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 100.665 | 78.28 | 33.255 | -33.687 | 0 | 160.792 | 0 | 96.196 | -0.04 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -38.802 | -131.43 | -116.464 | -108.011 | -256.785 | -78.28 | -33.255 | -108.56 | -220.461 | -160.792 | -89.659 | -96.196 | -673.465 | -275.311 | -215.939 | -48.291 | -7.001 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 123.697 | 133.407 | 161.802 | 130.035 | 156.12 | 178.147 | 187.1 | 142.247 | 110.899 | 106.498 | 121.848 | 79.807 | 70.33 | 142.036 | 200.872 | 204.158 | 205.691 | 173.096 | 177.701 | 129.834 |
| Other Investing Activites
| -31.346 | 0 | 45.338 | 22.024 | -100.665 | -78.28 | -33.255 | 33.687 | 160.792 | -160.792 | 32.189 | -96.196 | 539.501 | -275.311 | -215.899 | -48.291 | -141.422 | -250.4 | -270.502 | -239.032 |
| Investing Cash Flow
| 53.505 | 1.918 | 45.007 | 21.994 | -100.69 | 99.672 | 152.912 | 32.154 | 46.648 | -57.085 | 25.019 | -26.122 | -73.902 | -144.874 | -39.474 | 136.677 | 32.387 | -89.945 | -99.879 | -116.079 |
| Financing Activities: | ||||||||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | -0.965 | 0.862 | 0.103 | 0.882 | 0.072 | 1.246 | 0 | 9.577 | 5.127 | 1.57 | 2.555 | 10.502 | -0.531 | 393.492 | 0.884 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.734 | 0.81 | -0.076 | -0.123 | -0.215 | -0.05 | -0.069 | -0.094 | -0.367 | 0 | 0 | 0 | -0.531 | 0 | 0 | 0 | 0 | 0 | -16.05 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.437 | 0.103 | 0.862 | 0.027 | 0.759 | -0.143 | 1.196 | -0.069 | 0.863 | 4.76 | 2.457 | 2.555 | 7.399 | 0.529 | 0.63 | 0.884 | 0.338 | 0.035 | -0.002 | 488.225 |
| Financing Cash Flow
| 0.437 | 0 | 0.862 | 0.027 | 0.759 | -0.143 | 1.196 | -0.069 | 0.863 | 4.76 | 2.457 | 2.555 | 7.399 | -0.531 | 393.492 | 0.884 | 0.338 | 0.035 | -0.002 | 476.419 |
| Other Information: | ||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | -0.001 | -102.395 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 6.7 | -33.124 | 7.774 | -19.997 | -140.567 | 61.843 | 114.947 | -14.127 | 7.244 | -89.428 | -16.857 | -71.419 | -99.676 | -170.937 | 320.071 | 103.964 | 5.993 | -111.538 | -188.803 | 336.748 |
| Cash At End Of Period
| 107.287 | 100.587 | 133.424 | 125.65 | 145.647 | 286.497 | 224.654 | 109.707 | 123.834 | 116.59 | 206.018 | 222.875 | 294.294 | 393.97 | 564.907 | 244.836 | 140.872 | 134.879 | 246.417 | 435.22 |